Drug Evaluation Committee Q&A for Medical Education Meetings and Medical Booths
Medical Affairs Subcommittee
July 2021
In order to ensure that member companies can appropriately plan and operate academic seminars, symposia, etc. (above, medical education meetings) and medical booths planned and operated by medical affairs (MA), we have compiled and confirmed relevant industry rules and regulations, and have prepared a list of points to keep in mind when implementing such meetings and booths. The Drug Evaluation Committee's MA Subcommittee has compiled the following Q&A as a product of the Drug Evaluation Committee's MA Subcommittee. We hope that this information will be widely shared with all parties concerned.
July 2021
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee
MA Subcommittee
The "Q&A on the Implementation of Medical Education Meetings and Medical Booths" has been updated due to changes in the definitions of Medical Education Meetings and Medical Booths.
December 2022
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee
MA Subcommittee